Skip to main content
. 2020 Nov 5;2020(11):CD009669. doi: 10.1002/14651858.CD009669.pub4

Comparison 9. Dopamine‐milrinone versus dopamine‐dobutamine.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
9.1 All‐cause short‐term mortality 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
9.2 All‐cause short‐term mortality: sensitivity analysis 1   Risk Ratio (IV, Fixed, 95% CI) Totals not selected
9.3 Haemodynamics (Cardiac index) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
9.4 Haemodynamics (Pulmonary capillary wedge pressure) 1   Mean Difference (IV, Random, 95% CI) Totals not selected
9.5 Haemodynamics (Mean arterial pressure) 1   Mean Difference (IV, Random, 95% CI) Totals not selected